Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Mohit Khera , MD

Urology • Houston, TX

Active NPI 1669677381 Individual Practitioner Male Practitioner Accepts Medicare assignment Telehealth (some services)
Practice location in NPPES

6620 Main Street, Suite 1325
Houston, TX 77030

Call 7137984001 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

6620 Main Street
Suite 1325

Houston, TX 77030

Telephone 7137984001
Organization at the Same NPPES Address or Phone
St. Luke's Diagnostic Cath Lab, Llp Facility NPI 1841296357

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Baylor College Of Medicine. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

University Of Texas Medical School At San Antonio

Graduation Year

2000

Medicare patients

512 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $285,946 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $224,692 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

3,415 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$283,562 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $63,523.07 across 54 records.

By nature of payment (3 largest of 5)

  • Consulting Fee: $38,073.98 across 14 records.
  • Honoraria: $14,000.00 across 4 records.
  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $7,425.00 across 5 records.

Reporting-company totals (3 largest of 8)

  • Boston Scientific Corporation: $20,076.86 across 25 records.
  • Verity Pharmaceuticals Inc.: $16,485.96 across 7 records.
  • Antares Pharma, Inc.: $15,189.47 across 5 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

26 years (graduated 2000)

CMS Doctors and Clinicians data list 2000 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2007

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

Telehealth (some services)

Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.

What this does not show: Telehealth (some services)

It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Khera has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Khera as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Houston and Texas

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 85% of clinicians listed under Urology in Houston, TX (2024, 114 clinicians with data). Median for this group: 886. Middle half: 303 to 2,970.

More Medicare Part B services than 85% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: 1,747. Middle half: 624 to 4,672.

Medicare-allowed amount

A higher Medicare-allowed amount than 85% of clinicians listed under Urology in Houston, TX (2024, 114 clinicians with data). Median for this group: $91,388. Middle half: $36,538 to $190,368.

A higher Medicare-allowed amount than 80% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: $130,714. Middle half: $56,287 to $240,641.

Paid by Medicare

A higher Medicare payment amount than 85% of clinicians listed under Urology in Houston, TX (2024, 114 clinicians with data). Median for this group: $64,698. Middle half: $25,189 to $142,276.

A higher Medicare payment amount than 80% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: $98,137. Middle half: $41,252 to $184,582.

Medicare Part D prescriptions

More Part D prescriptions than 60% of clinicians listed under Urology in Houston, TX (2024, 126 clinicians with data). Median for this group: 835. Middle half: 187 to 2,299.

Close to the middle for clinicians listed under Urology in Texas (2024, 674 clinicians with data). Median for this group: 1,247. Middle half: 376 to 2,313.

Part D drug cost

A higher Part D drug cost than 75% of clinicians listed under Urology in Houston, TX (2024, 126 clinicians with data). Median for this group: $120,425. Middle half: $6,975 to $230,890.

A higher Part D drug cost than 65% of clinicians listed under Urology in Texas (2024, 674 clinicians with data). Median for this group: $145,258. Middle half: $28,676 to $353,758.

182 active clinicians are listed under Urology with a practice address in Houston, TX (968 in Texas).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Houston

44.5% of these 182 clinicians have the CMS telehealth indicator.

72% of these 182 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 54 records totaling $63,523.07.

Manufacturer Payment Nature Product Type Amount ($)
Antares Pharma, Inc.
Consulting Fee
Cash or cash equivalent
XYOSTED General $6,378.24
Antares Pharma, Inc.
Consulting Fee
Cash or cash equivalent
XYOSTED General $6,378.24
Endo USA, Inc.
Consulting Fee
Cash or cash equivalent
XIAFLEX General $5,990.00
Verity Pharmaceuticals Inc.
Honoraria
Cash or cash equivalent
Tlando General $5,000.00
Boston Scientific Corporation
Consulting Fee
Cash or cash equivalent
General - Erectile Dysfunction General $4,125.00
Boston Scientific Corporation
Consulting Fee
Cash or cash equivalent
General - Erectile Dysfunction General $3,300.00
Boston Scientific Corporation
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
AdVance XP General $3,300.00
Verity Pharmaceuticals Inc.
Honoraria
Cash or cash equivalent
Tlando General $3,000.00
Verity Pharmaceuticals Inc.
Honoraria
Cash or cash equivalent
Tlando General $3,000.00
Verity Pharmaceuticals Inc.
Honoraria
Cash or cash equivalent
Tlando General $3,000.00
Antares Pharma, Inc.
Consulting Fee
Cash or cash equivalent
XYOSTED General $2,375.00
COLOPLAST CORP
Consulting Fee
Cash or cash equivalent
Titan General $2,000.00
Novo Nordisk Inc
Consulting Fee
Cash or cash equivalent
— General $1,965.00
Boston Scientific Corporation
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
AdVance XP General $1,650.00
Boston Scientific Corporation
Consulting Fee
Cash or cash equivalent
General - Erectile Dysfunction General $1,650.00
Boston Scientific Corporation
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
General - Erectile Dysfunction General $1,100.00
Boston Scientific Corporation
Consulting Fee
Cash or cash equivalent
AMS 700 General $1,100.00
Verity Pharmaceuticals Inc.
Consulting Fee
Cash or cash equivalent
Tlando General $1,000.00
Boston Scientific Corporation
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
AdVance XP General $825.00
Verity Pharmaceuticals Inc.
Consulting Fee
Cash or cash equivalent
Tlando General $750.00
Verity Pharmaceuticals Inc.
Travel and Lodging
Cash or cash equivalent
Tlando General $735.96
Endo USA, Inc.
Consulting Fee
Cash or cash equivalent
XIAFLEX General $650.00
Boston Scientific Corporation
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
General - Erectile Dysfunction General $550.00
Boston Scientific Corporation
Consulting Fee
Cash or cash equivalent
AMS 700 General $412.50
Boston Scientific Corporation
Travel and Lodging
In-kind items and services
AMS 700 CXR RTE Kit General $379.71

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
4,150 14 $0.54 $0.08
84403 Testosterone (hormone) level, total
381 239 $84.00 $25.29
84270 Sex hormone binding globulin (protein) level
366 228 $118.00 $21.30
82670 Measurement of total estradiol (hormone)
341 207 $75.00 $27.26
84153 Psa (prostate specific antigen) measurement, total
287 182 $91.00 $17.91
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
277 204 $355.00 $129.04
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
247 188 $252.00 $92.73
11980 Placement of hormone pellet under skin
135 55 $477.00 $94.83
J3490 Unclassified drugs
118 52 $3004.00 $1044.46
51798 Ultrasound measurement of bladder capacity after voiding
93 81 $57.00 $11.48
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
92 92 $311.00 $114.38
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
63 51 $157.00 $57.61
52000 Diagnostic exam of bladder and urethra using an endoscope
61 52 $1197.00 $223.44
81002 Urinalysis, manual test
44 33 $11.00 $3.41
84154 Psa (prostate specific antigen) measurement, free
39 35 $91.00 $17.61
86316 Analysis for detection of tumor marker
36 33 $43.00 $19.89
81003 Automated urinalysis test
33 32 $9.00 $2.20
76775 Limited ultrasound scan behind abdominal cavity
30 27 $200.00 $58.86
51741 Electronic assessment of bladder emptying
26 25 $130.00 $10.53
76872 Ultrasound scan of pelvic region through rectum
25 23 $378.00 $139.41
82627 Dehydroepiandrosterone (dhea-s) hormone level
24 23 $96.00 $21.79
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
23 21 $501.00 $185.22
83001 Gonadotropin, follicle stimulating (reproductive hormone) level
21 21 $80.00 $18.21
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
21 21 $465.00 $171.87
83002 Gonadotropin, luteinizing (reproductive hormone) level
19 19 $80.00 $18.15

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Tamsulosin Hcl Tamsulosin Hcl 323 27,583 $6,188.21 122
Gemtesa Vibegron 107 6,210 $98,983.94 33
Alfuzosin Hcl Er Alfuzosin Hcl 96 7,774 $2,118.60 34
Finasteride Finasteride 73 6,210 $1,149.95 24
Testosterone Cypionate Testosterone Cypionate 73 3,616 $4,828.58 29
Testosterone Enanthate Testosterone Enanthate 68 3,503 $5,427.74 32
Anastrozole Anastrozole 63 5,329 $337.78 20
Levofloxacin Levofloxacin 55 234 $141.30 47
Testosterone Testosterone 54 2,820 $10,687.00 26
Ciprofloxacin Hcl Ciprofloxacin Hcl 46 461 $289.43 32
Oxybutynin Chloride Er Oxybutynin Chloride 44 3,600 $1,750.68 15
Trazodone Hcl Trazodone Hcl 44 2,595 $161.98 13
Meloxicam Meloxicam 41 1,470 $131.93 20
Myrbetriq Mirabegron 39 2,080 $31,040.22 16
Solifenacin Succinate Solifenacin Succinate 39 3,383 $1,486.93 15
Testopel Testosterone 37 3,264 $44,775.58 15
Dutasteride Dutasteride 34 2,957 $2,098.47 12
Mounjaro Tirzepatide 34 1,294 $45,972.98 —
Pentoxifylline Pentoxifylline 33 2,550 $1,207.86 14
Silodosin Silodosin 29 2,340 $3,027.80 13
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim 27 213 $89.44 21
Potassium Citrate Er Potassium Citrate 25 2,190 $2,461.08 13
Estradiol Estradiol 24 1,426 $3,667.38 —
Tadalafil Tadalafil 19 960 $1,601.98 —
Cabergoline Cabergoline 18 1,104 $1,300.52 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2020-11-20
Urology Primary Specialty

NUCC Taxonomy Code: 208800000X

License # reported to NPPES TX M6229

A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Texas Medical Board.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
189117801 (TX)
Medicaid ID
189117802 (TX)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - UROLOGY

Medicare Enrollment ID

I20070713000179

Enrollment State Jurisdiction

TX

PECOS Control ID

2163522582

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Baylor College Of Medicine

1919 Old Spanish Trl, Houston, TX 770542003

Baylor College Of Medicine

2 Greenway Plz, Houston, TX 770460205

Baylor College Of Medicine

6565 Fannin St, Houston, TX 770302703

Phone: 7137986374

Baylor College Of Medicine

6720 Bertner Ave, Houston, TX 770302604

Baylor College Of Medicine

6770 Bertner Ave, Houston, TX 770302604

Phone: 7137981000

Baylor College Of Medicine

7200 Cambridge St, Houston, TX 770304202

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

11 listed
Marshall Gonzales , PA-C

Physician Assistant

NPI 1952456915

Physician Assistant (Certified)

NPI 1851481816

Doctor of Medicine (M.D.)

Amy Lawrence , AGNP-C

Nurse Practitioner - Adult Health

NPI 1336604636

Adult-Gerontology Nurse Practitioner (Certified)

NPI 1669552063

Doctor of Medicine (M.D.)

NPI 1518057595

Doctor of Medicine (M.D.)

NPI 1811087851

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated June 21, 2007.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1669677381
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: June 21, 2007
Last Update: November 20, 2020
Sole Proprietor: No

Other Urology Specialists in Houston

All Urology Specialists in Houston

Mailing Address

Po Box 4504

Houston, TX 772104504

Phone: 7137981750

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.